Natalie Slowik1, Shuren Ma1, Jiangtao He1, Yong Y Lin1, Offie P Soldin2, Richard A Robbins3, Gerard M Turino4. 1. Department of Medicine, St. Luke's Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY. 2. Departments of Oncology and Medicine, Georgetown University Medical Center, Washington, DC. 3. University of Arizona, Phoenix, AZ. 4. Department of Medicine, St. Luke's Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY. Electronic address: gmt1@columbia.edu.
Abstract
BACKGROUND: Tobacco smoke is a major risk factor in the development of COPD. Secondhand smoke (SHS) exposure is a known risk factor in asthma, bronchitis, and coronary artery disease. Elastin is a recognized target for injury in COPD, and the amino acids desmosine and isodesmosine (D/I), which are specific for elastin degradation, are elevated in COPD. This study determined whether exposure to SHS affects elastin degradation in asymptomatic individuals. METHODS: Two cohorts of asymptomatic individuals without evidence of respiratory or circulatory disease, exposed to SHS, were studied. Both cohorts comprised normal nonsmokers, active smokers, and those exposed to SHS. D/I were measured in plasma and quantified by high-performance liquid chromatography and tandem mass spectrometry by published methods. Plasma cotinine, a metabolite of nicotine, was also measured. RESULTS: In each cohort, the levels of D/I in plasma were statistically significantly higher in secondhand-smoke-exposed subjects than in the normal nonexposed subjects. Smokers had the highest levels of D/I but their levels were not statistically significantly higher than those of the secondhand-smoke-exposed. Cotinine levels were elevated in secondhand-smoke-exposed subjects and active smokers but not in most nonsmoking control subjects. CONCLUSIONS: Results indicate a tissue matrix effect of degradation of body elastin from SHS exposure and possible lung structure injury, which may result in COPD. Long-term studies of individuals exposed to SHS for the development of COPD are warranted.
BACKGROUND:Tobacco smoke is a major risk factor in the development of COPD. Secondhand smoke (SHS) exposure is a known risk factor in asthma, bronchitis, and coronary artery disease. Elastin is a recognized target for injury in COPD, and the amino acids desmosine and isodesmosine (D/I), which are specific for elastin degradation, are elevated in COPD. This study determined whether exposure to SHS affects elastin degradation in asymptomatic individuals. METHODS: Two cohorts of asymptomatic individuals without evidence of respiratory or circulatory disease, exposed to SHS, were studied. Both cohorts comprised normal nonsmokers, active smokers, and those exposed to SHS. D/I were measured in plasma and quantified by high-performance liquid chromatography and tandem mass spectrometry by published methods. Plasma cotinine, a metabolite of nicotine, was also measured. RESULTS: In each cohort, the levels of D/I in plasma were statistically significantly higher in secondhand-smoke-exposed subjects than in the normal nonexposed subjects. Smokers had the highest levels of D/I but their levels were not statistically significantly higher than those of the secondhand-smoke-exposed. Cotinine levels were elevated in secondhand-smoke-exposed subjects and active smokers but not in most nonsmoking control subjects. CONCLUSIONS: Results indicate a tissue matrix effect of degradation of body elastin from SHS exposure and possible lung structure injury, which may result in COPD. Long-term studies of individuals exposed to SHS for the development of COPD are warranted.
Authors: Daniel Menzies; Arun Nair; Peter A Williamson; Stuart Schembri; Mudher Z H Al-Khairalla; Martyn Barnes; Tom C Fardon; Lesley McFarlane; Gareth J Magee; Brian J Lipworth Journal: JAMA Date: 2006-10-11 Impact factor: 56.272
Authors: Peter H Whincup; Julie A Gilg; Jonathan R Emberson; Martin J Jarvis; Colin Feyerabend; Andrew Bryant; Mary Walker; Derek G Cook Journal: BMJ Date: 2004-06-30
Authors: Demosthenes B Panagiotakos; Christos Pitsavos; Christina Chrysohoou; John Skoumas; Constadina Masoura; Pavlos Toutouzas; Christodoulos Stefanadis Journal: Am J Med Date: 2004-02-01 Impact factor: 4.965
Authors: Sara Ongay; Marijke Sikma; Peter Horvatovich; Jos Hermans; Bruce E Miller; Nick H T Ten Hacken; Rainer Bischoff Journal: Chronic Obstr Pulm Dis Date: 2016-03-01
Authors: Jelena Mustra Rakic; Siyang Zeng; Linnea Rohdin-Bibby; Erin L Van Blarigan; Xingjian Liu; Shuren Ma; John P Kane; Rita F Redberg; Gerard M Turino; Eveline Oestreicher Stock; Mehrdad Arjomandi Journal: Chronic Obstr Pulm Dis Date: 2022-07-29
Authors: Robert C Spitale; Michelle Y Cheng; Kimberly A Chun; Emily S Gorell; Claudia A Munoz; Dale G Kern; Steve M Wood; Helen E Knaggs; Jacob Wulff; Kirk D Beebe; Anne Lynn S Chang Journal: Genome Med Date: 2012-02-23 Impact factor: 11.117